About four million doses of the COVID-19 vaccine arrived Nigeria on Tuesday.
The vaccine was shipped to Nigeria through the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO.
The 3.94 million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India, arrived from Mumbai to Abuja around 11.30 am.
A presidential aide, Bashir Ahmed, announced the development on Twitter.
“Nigeria has just received the first batch of Oxford/AstraZeneca COVID—19 vaccine,” Ahmad tweeted.
The United Nations said it will support the vaccination campaign in Nigeria.
UN Resident Coordinator in Nigeria, Edward Kallon, said, “The UN Country Team in Nigeria reiterates its commitment to support the vaccination campaign in Nigeria and help contain the spread of the virus.
“The arrival of these vaccines in Abuja today marks a milestone for the COVAX Facility in its
unprecedented effort to deliver at least 2 billion doses of COVID-19 vaccines globally by the end of 2021.”
Managing Director for Country Programmes at Gavi, the Vaccine Alliance, Thabani Maphosa, added, “This is a landmark moment for the country and the COVAX Facility’s mission to help end the acute phase of the pandemic by enabling equitable access to these vaccines across the world.
“We are glad to see Nigeria is amongst the first receiving the doses from COVAX, thanks to the excellent level of preparedness put in place by the Government of Nigeria.”
The National Primary Health Care Development Agency had said it would commence the vaccination of Nigerians in priority groups, starting with frontline healthcare workers.
Untitled Document
You can always reach us through these channels
Facebook:https:/www.facebook.com/ancitymedia
Instagram: https://www.instagram.com/ancitymedia
Youtube Channel:https://youtube.com/@ancitymedia
Phone Numbers: 07062501185, 09038738731
E-Mail: info@ancity.com.ng, anambracity@gmail.com
Copyright.
This Post: COVID-19 vaccine arrives Nigeria was approved and published by Ancity Media Editor and may not be republished elsewhere without prior written permission from the Editor.
